SECRETOME ACTIVITY ANALYSIS Russian patent published in 2023 - IPC G01N33/50 

Abstract RU 2790567 C2

FIELD: cell biology; medicine.

SUBSTANCE: present invention relates to cell biology and medicine, in particular to methods for determination of activity of supernatant of a mammalian cell culture for use in the treatment of an inflammatory condition. For implementation of the specified methods, first, SH-SY5Y cells containing an expression cassette containing an activating protein 1 (hereinafter – AP-1) promotor functionally connected to a nucleic acid molecule encoding reporter protein are incubated in a cultural medium containing or consisting of the specified supernatant, and promotor activity of AP-1 promotor is measured. Then, A549 cells containing an expression cassette containing NF-kB promotor functionally connected to a nucleic acid molecule encoding reporter protein are incubated in a cultural medium containing or consisting of the specified supernatant, and promotor activity of NF-kB promotor is measured. Next, A549, HEK293, Ha-Cat, and/or SH-SY5Y cells are incubated in a cultural medium containing or consisting of the specified supernatant, and amount of phosphorylated heat shock protein 27 (hereinafter – HSP27) released with eucaryotic cells into the cultural medium is measured. In this case, a decision is made that supernatant of the mammalian cell culture has a potential for use in the treatment of an inflammatory condition, if promotor activity of at least one of AP-1 and NF-kB promotors is at least 50% higher than promotor activity of AP-1 and NF-kB promotors, measured when eucaryotic cells are cultivated in a cultural medium not containing the specified supernatant, and if amount of HSP27 released into the cultural medium is at least 20% higher than amount of phosphorylated HSP27 released into the cultural medium, when eucaryotic cells are cultivated in a cultural medium not containing the specified supernatant.

EFFECT: present invention allows for expansion of the arsenal of methods for activity analysis for measuring biological activity and therapeutic efficiency of conditioned cultural media by means of monitoring of expression of specific proteins and/or regulation of specific promotors.

10 cl, 13 dwg, 1 tbl, 8 ex

Similar patents RU2790567C2

Title Year Author Number
INDUCIBLE PROMOTER, VECTOR AND HOST CELL BASED THEREON 2021
  • Kononov Aleksej Vladimirovich
  • Zhiryakova Mariya Vladimirovna
  • Gordeev Aleksandr Andreevich
  • Puchkova Mariya Yurevna
  • Solovev Valerij Vladimirovich
  • Morozov Dmitrij Valentinovich
RU2820059C2
PIGAS CELL LINE CONTAINING STAT-1 TRANSCRIPTION FACTOR BINDING SITE STABLE-INTEGRATED IN GENOME 2015
  • Kulikova Kseniya Valerevna
  • Konyaeva Ekaterina Pavlovna
  • Lukashina Marina Igorevna
  • Gnuchev Nikolaj Vasilevich
  • Georgiev Georgij Pavlovich
  • Larin Sergej Sergeevich
RU2619643C1
TEST SYSTEM FOR ANALYSING FUNCTIONAL ACTIVITY OF ANTIBODIES AGAINST PD-1 AND ANTIBODIES AGAINST PD-L1 2019
  • Doronin Aleksandr Nikolaevich
  • Gordeev Aleksandr Andreevich
  • Solovev Valerij Vladimirovich
  • Basovskij Yurij Ivanovich
  • Kozlov Aleksej Evgenevich
  • Smirnova Yana Andreevna
  • Puchkova Mariya Yurevna
  • Ekimova Viktoriya Mikhajlovna
  • Ivanov Roman Alekseevich
  • Morozov Dmitrij Valentinovich
RU2731896C1
NOVEL EUKARYOTIC CELLS AND METHODS FOR PREPARING THEREOF FOR RECOMBINANT EXPRESSION OF PRODUCT OF INTEREST 2014
  • Dzhostok Tomas
  • Lauks Kholger
  • Ritter Anett
RU2712507C2
COMPOSITIONS CONTAINING DPP-4 INHIBITOR FOR PREVENTION OR TREATMENT OF VALVE CALCIFICATION 2015
  • Chang, Eun-Ju
  • Song, Jae-Kwan
  • Kim, Mi Jeong
  • Choi, Bongkun
  • Lee, Sahmin
RU2680527C1
EUKARYOTIC EXPRESSION VECTORS CONTAINING REGULATORY ELEMENTS OF GLOBIN GENE CLUSTERS 2016
  • Danielczyk, Antje
  • Jahn, Doreen
  • Goletz, Steffen
RU2716974C2
MODIFIED ONCOLYTIC ADENO VIRUSES 2019
  • Ranki, Tuuli
  • Pesonen, Sari
  • Prikha, Petri
  • Ilesmyaki, Erkko
  • Cherullo, Vinchentso
  • Martins, Beatris
RU2788638C2
IMPROVED VECTOR EXPRESSING TOLL-LIKE RECEPTOR AND AGONIST, AND USE IN CANCER THERAPY 2014
  • Gudkov Andrej
  • Mett Vadim
RU2682762C2
METHOD OF PRODUCING POLYPEPTIDES 2015
  • Gepfert Ulrikh
  • Morits Bendzhamin
RU2699715C2
NUCLEOTIDE SEQUENCE ABLE TO INHIBIT IL-6 ACTIVITY, PLASMID VECTOR FOR TRANSFECTION INTO MAMMALIAN CELLS, NUCLEOTIDE SEQUENCE USED IN THERAPY, PHARMACEUTICAL COMPOSITION (VARIANTS) 1995
  • Serlupi-Kreshentsi Ottaviano
  • Petstsotti Annarita
RU2205874C2

RU 2 790 567 C2

Authors

Ankersmit, Hendrik Jan

Mildner, Michael

Dates

2023-02-27Published

2018-12-19Filed